Conmed (CNMD) Misses Q1 EPS by 2c, Offers FY15 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Ladenburg Thalmann Downgrades CONMED (CNMD) to Neutral
April 24, 2015 8:19 AM EDTLadenburg Thalmann downgraded CONMED (NASDAQ: CNMD) from Buy to Neutral with a price target of $55 (unchanged).
For an analyst ratings summary and ratings history on CONMED click here. For more ratings news on CONMED click here.
Shares of CONMED closed at $54.23 yesterday.
... More